Dog Rose Hip

Dog rose hip (Rosa canina) fruit contains the bioactive galactolipid GOPO, which suppresses COX-2 and inducible nitric oxide synthase (iNOS) in activated macrophages, reducing key inflammatory mediators implicated in osteoarthritis and joint degradation. The fruit delivers exceptionally high vitamin C (up to 2,500 mg/100 g dry weight), alongside polyphenols, carotenoids, and polyunsaturated fatty acids—compounds whose anti-inflammatory efficacy in osteoarthritic subjects has been demonstrated in dose-titration studies showing significant reductions in lameness and pain scores (Fritsch et al., 2010; PMID: 20707845).

Origin & History

Dog Rose Hip (Rosa canina) is the fruit of the Dog Rose plant, native to Europe, Northwest Africa, and Western Asia. It is highly prized for its exceptional vitamin C content and potent antioxidant profile, making it a cornerstone for immune and skin health.

Historical & Cultural Context

Dog Rose Hip holds deep cultural and historical significance in European and Middle Eastern traditions, associated with immunity, vitality, and beauty. Revered in ancient Rome for its medicinal uses, it symbolized health in folklore and continues to be valued globally for its diverse health benefits.

Health Benefits

- Strengthens immune function and enhances collagen synthesis with exceptionally high vitamin C content.
- Protects against oxidative stress through its rich profile of flavonoids, carotenoids, and polyphenols.
- Promotes cardiovascular health by reducing arterial inflammation and improving circulation.
- Provides anti-inflammatory benefits for joint health, easing symptoms like osteoarthritis.
- Supports digestive wellness through dietary fiber, promoting gut microbiome balance and regularity.
- Enhances wound healing and skin hydration.
- Contributes to cognitive clarity through neuroprotective effects.

How It Works

The primary bioactive in dog rose hip, GOPO ((2S)-1,2-di-O-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]-3-O-β-D-galactopyranosyl glycerol), is a galactolipid that inhibits cyclooxygenase-2 (COX-2) gene expression and suppresses inducible nitric oxide synthase (iNOS) activity in lipopolysaccharide-stimulated macrophages, thereby reducing prostaglandin E₂ (PGE₂) and nitric oxide (NO) production—two central mediators of inflammatory joint destruction. Additionally, rose hip's high concentrations of ascorbic acid, quercetin, and trans-tiliroside act synergistically to scavenge reactive oxygen species (ROS), inhibit NF-κB nuclear translocation, and downregulate matrix metalloproteinases (MMP-1, MMP-3, MMP-13) responsible for cartilage collagen degradation. The omega-3 fatty acids (α-linolenic acid) present in the seed fraction competitively inhibit arachidonic acid metabolism via the COX and 5-lipoxygenase (5-LOX) pathways, shifting eicosanoid production toward anti-inflammatory resolvins and protectins. Dose-dependent anti-inflammatory responses observed with polyunsaturated fatty acid supplementation in osteoarthritic models (Fritsch et al., 2010; PMID: 20707845) support this multi-target mechanism.

Scientific Research

Fritsch et al. (2010) conducted a dose-titration study of polyunsaturated fatty acid supplementation in osteoarthritic dogs and demonstrated significant dose-dependent reductions in lameness, weight-bearing pain, and overall arthritis severity (J Vet Intern Med; PMID: 20707845). Osojnik Črnivec et al. (2014) analyzed spent Rosa canina L. rose hips and confirmed that substantial bioactive compounds—including polyphenols, organic acids, and residual lipids—are retained even after industrial extraction, validating rose hip's nutraceutical potential for supplement formulations (Bioresour Technol; PMID: 25218210). Oberbauer et al. (2018) investigated maternal omega-3 polyunsaturated fatty acid supplementation and its effects on offspring hip joint conformation, finding measurable improvements in joint morphology that underscore the role of fatty acid profiles—similar to those found in rose hip seed oil—in musculoskeletal development (PLoS One; PMID: 30092106).

Clinical Summary

Clinical trials testing rose hip extracts have shown mixed results, with one study of a flavonoid-carotenoid complex from R. canina failing to demonstrate efficacy. In vitro studies confirm GOPO's ability to inhibit COX-2 transcription in TPA-treated B16 cells and show chondroprotective effects. Antioxidant activity has been validated in laboratory studies of eight Transylvanian extracts using DPPH assays, correlating with vitamin C and total polyphenol content. Large-scale clinical trials with quantified therapeutic outcomes remain limited in the current literature.

Nutritional Profile

- Vitamin C, B Vitamins
- Calcium, Magnesium, Potassium
- Dietary Fiber, Pectin
- Flavonoids (Quercetin, Kaempferol), Carotenoids (Beta-carotene, Lycopene), Galactolipids

Preparation & Dosage

- Traditionally used in herbal teas, syrups, jams, and jellies to boost immunity and treat respiratory infections.
- Valued in European folk medicine for gastrointestinal support, respiratory conditions, and wound healing.
- Modern uses include extracts in immune support supplements, joint health formulations, and beauty products.
- Recommended dosage is 1–2 grams dried fruit steeped in hot water or 500–1000 mg standardized extract daily.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Immune & Inflammation | Skin & Collagen
Primary Pairings: - Turmeric (Curcuma longa)
- Camu Camu
- Ginger (Zingiber officinale)
- Sea Buckthorn (Hippophae rhamnoides)

Safety & Interactions

Dog rose hip is generally recognized as safe (GRAS) with no serious adverse effects reported in clinical trials at standard dosages (5–10 g/day of powder in humans; weight-adjusted doses in canines). Due to its high vitamin C content, rose hip may theoretically enhance iron absorption and should be used cautiously in individuals with hemochromatosis or iron overload conditions. While no significant CYP450 interactions have been documented, the flavonoid quercetin present in rose hip is a known in vitro inhibitor of CYP3A4 and CYP2C9, so concurrent use with warfarin, cyclosporine, or other narrow-therapeutic-index drugs metabolized by these enzymes warrants clinical monitoring. Mild gastrointestinal effects (nausea, diarrhea) have been reported at high doses due to the dietary fiber and organic acid content, and individuals with known Rosaceae allergies should avoid supplementation.